What should patients do instead of waiting for retatrutide
Funding Author, CAK, received a student scholar research stipend from the Child Injury Prevention Alliance while she worked on this study
At the time of diagnosis of clinical ASCVD in a patient with T2D on a drug regimen that does not include a GLP-1 RA or an SGLT-2 inhibitor with demonstrated cardiovascular benefit
This article is part of the PlexusDx Education Hub, our home for grounded guidance on GLP-1 therapies, weight-management protocols, and the genetics that shape them
cDNA was subsequently generated by TaKaRa PrimeScript RT reagent Kit (Takara, RR037A)
SSZ has significant efficacy in reducing active joint counts and slowing radiographic progression, which is comparable to the effects of Leflunomide